ArticlePloS one2020
Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world.
Yoon-Kyoung Sung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticlePloS one2020
Yoon-Kyoung Sung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.